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Abstract 
Objective: Atypical meningioma are an 
intermediate group of meningiomas, 
exhibiting less favourable biological 
behavior than classic benign tumours, but a 
relatively more favourable biological 
behavior than definitive malignant 
meningiomas. Subject of controversy, 
atypia in meningioma still generate 
discordance between accurate criteria 
defining malignancy and biological 
behavior, prediction of recurrence. 
Methods: This retrospective study intend 
to evaluate diagnosis on clinical and 
pathological data, treatment trends and 
early outcomes for 6 cases with atypical 
meningiomas occuring in 63 patients 
operated for benign meningioma in the last 
5 years in our clinic between 2006-2011. All 
patients were explored CT, MRI, 
preoperative selective angiography and in all 
cases the WHO 2000 classification criteria 
were used to define atypical meningioma  
Results: Between 2006-2011 we operated 
6 atypical meningioma of 63 benign 
meningiomas (9,52%). Tumor sites in the 
patients were: parasagittal (3 cases), 
convexity (2 cases), spheno-cavernous (1 
case). All patients were operated and dural 
graft was done to all cases. The extent of 
surgical resection was Simpson’s grade 1 in 
2 cases and Simpson’s grade 2 in four cases, 
to which radiation was administered after 
the first surgery with a dose ranging from 
52-62 Gy. Regrowth (enlargement of 
tumour after subtotal resection) was 
noticed in 2 irradiated cases: one case after 2 
years after the first operation, the patient 
was again operated - pathological diagnosis 
was malignant meningioma; in another case 
after 3 years, at operation it was the atypical 
meningioma. No chemotherapy was used 
in our cases. 
Conclusions: Atypical meningiomas are 
rare tumors, grow more rapidely, the 
diagnosis age ≥ 60 years, several 
histological criteria can define accurate 
identification to understand the biology of 
this group of tumors. Heterogenous 
contrast enhancement with marked 
peritumoral edema in neuroimaging are 
important; cerebral edema has prognostic 
value and should encourage fundamental 
and farmacologic research using anti VEGF 
and somatostatine analogs treatments. 
Surgery (Simpson grade 1) referring both 
tumor and dural implant area should be 
done de novo but also for recurrencies. 
Radiotherapy still are controversial without  
proven benefit and chemotherapy without 
statistic argues to improve quality of life. 
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Introduction 
Despite maningiomas are considered 
benign tumors, slow growing, very little 








the brain tissue, less likely to recur; atypical 
meningioma remain a controversial topic 
because of the limited signs of histological 
anaplasia, lack of universally accepted 
criteria for grading histological malignancy 
few large series have been conducted to 
evaluate the problem of malignancy and 
because biological behavior, prediction of 
recurrence is still difficult to predict.  Our 
study present our experience with such 
tumors between 2006-2011, operated in our 
clinic. 
Materials and methods 
6 cases with atypical meningiomas 
occuring in 63 patients operated for benign 
meningioma in the last 5 years in our clinic 
between 2006-2011 were evaluated pre and 
postoperatory, also at 1 and 2 years after. All 
patients were explored CT, MRI, 
preoperative selective angiography 
concerning topography, unique or multiple 
tumors, the presence of irregular margins 
and fringes, even prominent tumour 
pannus extending away from the globoid 
mass, the pattern of enhancement, the 
degree of peritumoral oedema, 
calcifications, brain invasion, spontaneous 
necrosis in the absence of embolization, 
vascularization. In all cases the WHO 2000 
classification criteria were used to define 
atypical meningioma on pathological data. 
All patients were operated on once aiming 
for gross total resection of the tumour as 
well as its overlying dura. The extent of 
surgical resection was graded according to 
Simpson’s classification. 
Results 
In the last 5 years 63 meningiomas were 
operated on at Neurosurgery Clinic 
Universitary Hospital Bucharest; of this 6 
(9,52%) were atypical meningiomas. Patient 
age were  range 53-78,  mean age 67; there 
was four males and two females; no signs of 
neurofibromatosis type 2 or another 
associated tumoral pathologies were 
noticed.  At presentation all patients had 
intracranial hypertension syndrome: 
headache, papillary oedema, confusion 1 
case; also slight hemiparesis or only limb 
paresis, focal seizures.  
Tumor sites in our patients were: 
parasagittal (3 cases), convexity (2 cases), 
spheno-cavernous (1 case). Cerebral MRI 
an CT scans were done in all patients. The 
tumors were slighty hyperdense with no 
calcification.  
All tumours exhibited homogenous 
dense contrast enhancement, with marked 
or moderate peritumoral oedema, irregular 
tumor margins. Angiography was 
performed in all cases with homogenous 
vascular blush, in two convexity 
meningiomas vascular feeders were seen 
from external carotid artery suited by 




















Figure 1  A-C pre and postop CT scan in frontal 
atypical meningioma with important perilesional 
oedema; D-E pre-op CT scan and F-G MRI of a 
spenocavernous atypical meningioma; H post-op CT 
scan 
 
All patients were operated and dural 
graft (autologous or synthetic) was done to 
all cases. The extent of surgical resection 
was Simpson’s grade 1 in 2 cases and 
Simpson’s grade 2 in four cases, to which 
radiation was administered after the first 
surgery with a dose ranging from 52-62 Gy.  
Pathological characteristics in all cases 
were based according to the WHO 2000 
classification: at least 4 mitoses in 10 hpf or 
3 of the following criteria: increased 
cellularity, high nuclear-to-cytoplasm 
ratios, prominent nucleoli, uninterrupted 
patternless or sheet-like growth or necrosis. 
(Figure 2) 
The median follow-up was 26 months 
(range 12 - 48 months). All patients with 
atypical meningioma in our series survived. 
Regrowth (enlargement of tumour after 
subtotal resection) was noticed in 2 






Figure 2 Atypical meningioma – pathological 
characteristics: A. necrosis (HE X 20), B increased 
cellularity and sheet-like growth (HE X 20), C 
prominent nucleoli (HE X 40),  cellular atypia (HE 
X 40) 
 
one case after 2 years after the first 
operation, the patient was again operated - 
pathological diagnosis was malignant 
meningioma; in another case after 3 years, 
at operation it was the atypical meningioma. 
No chemotherapy was used in our cases. 
Discussion 
Usually benign, recognized as a clinical 
entity for nearly 200 years, arising from 
arachnoidal cells of neural crest (1)(2)(3), 
meningiomas are the most common, 
primary, intracranial extraaxial brain 
tumours and comprise 13-20% of all 
primary intracranial neoplasms; they can 
invade dura and the skull by osseous 
hyperplasia (4). Acordind to the WHO 
classification system 2000 (5)(6), 
meningiomas are regarded as a 








histologically categorized into 14 distinct 
subgroups with three grades of malignancy: 
- benign (Grade I – typical 
meningiomas) - 90%:  meningothelial, 
fibrous, transitional, psammomatous, 
microkystic, angioblastic (most aggressive), 
metaplasic; these tumours exhibit slow 
growth and very little multiplication of cells 
and very rarely invade the brain tissue.  
Overall, benign meningiomas are less likely 
to recur than the atypical and malignant 
grades. 
- atypical (Grade II- M2, atypical)  - 5%-
10%:  atypical variants of their original 
histologic types: meningothelial, 
fibroblastic, transitional, including brain 
invasion, chordoid (foci of chordoid similar 
to a chordoma), clear cell (poligonal cells 
with clear cytoplasma by glicogen 
accumulation). It’s to be remarked that dura 
and adjacent bone invasion are not atypia 
signs. These tumours exhibit increased 
cellularity, cell abnormalities: prominent 
nucleoli, small cells, modified cell 
architecture, spontaneous necrosis in the 
absence of embolisation, a faster growth 
rate than benign meningiomas, some 
degree of brain invasion and a higher 
likelihood of recurrence than benign. 
- anaplastic (Grade III – M3, malignant) 
- 3-5% of all meningiomas: - papillary, 
rhabdoid, anaplastic. These tumours show 
frequent mitoses, increased cellular 
abnormalities, high nuclear to cytoplasmic 
ratio, foci of necrosis; exibit a faster growth 
rate compared to benign and atypical 
meningiomas, recur and are the most likely 
to invade the brain and spread (metastasize) 
to other organs in the body. 
Accordind to WHO 2000 classification 
(5) atypical meningiomas have at least: 3 of 
the 5 following criteria: increased 
cellularity, high nuclear to cytoplasm ratios, 
prominent nucleoli, uninterrupted 
patternless or sheet-like growth or necrosis; 
also 4 mitoses in 10 hpf (x400). The new 
WHO 2007 classification mentain the 
ancient classification, for atypical 
meningioma; brain invasion is not a criteria, 
but is recognised as an evolutivity criteria 
(7).  Although recognised as as pronostic 
factors of agresivity: brain invasion, elevated 
MIB-1 labeling (8)(9) and Ki67 
proliferative cells are not criteria for atipic 
meningioma (10), despite recognized 
predisposition for tumor recurrence and 
overal survival (10) when these factors are 
noted. Nagashima (11)(12)  has noted c-
myc expression level, the protooncogene 
and his protein proving positive correlation 
between c-myc expression level and the 
proliferative cell index by anti Ki67 
immunomarking. Their etiology is 
uncertain, but typical meningiomas may 
undergo gene losses and gains, 
transforming them into atypical ones (13). 
Radiation-induced meningiomas are also 
more likely to be atypical (14) 
Atypical meningiomas are rare, more 
aggressive and invasive than typical 
meningiomas, grow more rapidely, become 
symptomatic at an earlier age, are 
predominant in adults (2)(10)(15-21). 
Interesting especially the 4th and 5th 
decade, age egal or over 60 years are a 
negative prognostic facto in multivariants 
analisis. Considering gender distribution, 
asa in our cases, the female prodominance 
of 2/1 seen in benign meningiomas are no 
more observed, there is a inversion 
tendency for men for meningioma 
progressing from atypical to malignant 
meningioma, even biochemical studies have 
shown that progesterone activity correlates 
inversely with atypical in meningiomas. 








reflection of increased peritumoral oedema 
in atypical meningioma are more likely 
related with objective neurological deficits 
(22). More common atypical meningioma 
occur over cerebral convexities, parasagittal 
and falx;, few reports identify other 
locations as: infratentorially, supra and 
infratentorial extensions, intraventricularly 
(2). 
CT as MRI could not be an indicative to 
differentiate benign from atypical 
meningiomas, also to predict aggressive 
potential. Atypical meningiomas may be 
plaquelike in configuration and extend 
through the dura to the skull and scalp or 
can spread via the Perivascular Spaces (14) 
Marked peritumoral oedema, 
heterogenous contrast enhancement in 
5,4%, minimal or calcifications absence, 
irregular or indistinct margins, musjroom-
like projections of the main tumor mass are 
the most important findings in atypical 
meningiomas. (2)(15)(20)(22-24). DWI 
(diffusion-weighted imaging) signal 
intensity of tumors classified as hypo-, iso- 
or hyper-intense to grey matter and 
apparent diffusion coefficient (ADC) 
measurements to differentiate benign from 
atypical/malignant meningiomas and among 
different sub-types do not seem reliable in 
grading meningiomas or identifying 
histological sub-types. Hence, these 
parameters should not be recommended for 
surgical or treatment planning.(6) 
Concerning cerebral oedema in atypical 
meningiomas several considerations could 
be stated: there is no correlation between 
peritumoral oedema and tumor grade in 
meningioma (25), a significant  relation was 
statued between microvascular density, the 
value of the vascular endothelial growth 
factor expression (VEGF) known also as a 
vascular permeability factor and some 
somatostatine receptors (sst2) (26). 
Somatostatine by his receptors has an 
antiproliferative activity on several cells (27) 
for this reason these receptors  offers new 
tendency for research in tumor recurrency 
treatment. 
In the absence of a prospective study 
concerning the surgery effect on 
meningioma (28) The best attitude still is 
the  surgical approach with large dural 
implant base resection, to reduce 
recurrency and mortality.(2)(19)(29)  Using 
a univariate analysis Palma (16) has proved 
that Simpson 1 rezection versius 2-3 can 
improve global survival for  atypical 
meningiomas (P<0,0071), especially when 
tumor is on convexity. To improve tumor 
resection several methods were used: 
neuronavigation, somatostatine  analogs 
used intraoperatory for a better 
identification (30), specific imaging - 
octreoscan, microsurgery (6). 
Radiation therapy in the treatment of 
atypical meningioma still are controversial 
(2)(31). Despite classical conception of 
meningioma radioresistance, radiotherapy 
was used indifferent of the extent of 
surgical resection, the mean dosis 53,57 
gray +/_6,06 grays. On retrospective 
studies radiotherapy has doubtful results 
without consensus: some authors 
recommend radiotherapy after the first 
recurrency 60,5%, another authors proved 
that radiotherapy  has no impact on general 
survival and even can deteriorate prognosis. 
Radiotherapy should be proposed especially 
when tumor is passing from grade 2 to 3. 
Radiotherapy did no prevent or retard the 
recurrence of tumours regardless of the 
extent of resection (31). No chemotherapy 
is usefull (6). Despite gross total resection, 
approximately 29-40% of atypical 








grade tumours correlated with specific 
histological features have produce 
conflicting data (21). 
Conclusions 
Atypical meningiomas are rare tumors, 
with uncertain etiology, grow more 
rapidely, the diagnosis age ≥ 60 years, 
several histological criteria can define 
accurate identification to understand the 
biology of this group of tumors. 
Heterogenous contrast enhancement with 
marked peritumoral edema in 
neuroimaging are important; cerebral 
edema has prognostic value and should 
encourage fundamental and farmacologic 
research using anti VEGF and 
somatostatine analogs treatments. Surgery 
(Simpson grade 1) referring both tumor 
and dural implant area should be done de 
novo but also for recurrencies. 
Radiotherapy still are controversial without  
proven benefit and chemotherapy without 
statistic argues to improve quality of life. 
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